«Acticomp» starts deliveries of APIs to the Republic of Cuba
On the 8th of June 2023 in Sochi, at the site of the exhibition "Eurasia is Our Home", a Memorandum of Understanding was signed between Acticomp JSC and BioCubaPharma, a biotechnological and pharmaceutical Group of the Republic of Cuba.
Also, a contract was signed for the supply of active pharmaceutical ingredients (APIs) to PharmaCuba, a member of the BioCubaPharma Group, for a total amount of about $2 million until the end of 2023.
The Memorandum and Supply contract were signed by the President of the BioCubaPharma Group, Eduardo Martinez Diez, and Igor Ponamarev, Deputy General Director for Foreign Economic Activity of Acticomp JSC. The signing ceremony was also attended by the Prime Minister of the Republic of Cuba, Manuel Marrero Cruz.
The purpose of the Memorandum is to establish a strategy for cooperation in the field of research, development, production, investment and marketing of active ingredients and their reference materials for the production of priority medicines in the Russian Federation and Cuba, as well as in the other countries.
The PharmaCuba Company will become the representative of the Acticomp JSC in terms of selling its products to the market of Cuba, as well as other Latin American countries.
The first delivery of APIs will take place before the end of June. Future plans include expanding the list of APIs for distribution.